u/emeka_beaulieu
Contributes reviews on supplier material. Based in Oulu.
member · joined 15 Jun 2025
Comments — page 2 of 4
comment on packaging: what the trials say vs what this community says in c/coldchain · 101 points · 3 months ago
Customs clearance took 12 days. Package sat unrefrigerated during that. Powder tested clean after, reconstituted solution probably would not have.
comment on 23 months in and Apotheke is still the thing I get wrong in c/glp1eu · 31 points · 3 months ago
pharmacy stock varies by country and season
comment on [Results] 42 weeks, 21kg, and purity was the hard part in c/coa · 444 points · 3 months ago
Disagree. What you are describing is consistent with area percent, not with what you concluded.
comment on week 16 check-in — 36kg down, sulphur burps manageable, one thing confusing me in c/glp1uk · 8 points · 3 months ago
I am going to push back on this slightly.
comment on three years of packaging threads, summarised so you do not have to read them in c/coldchain · 145 points · 4 months ago
Half-life is about 168 hours, so steady state lands around week 14–5. Practical consequence: what you feel in week 1 is not what that dose does.
comment on amylin: the version I wish someone had shown me in week 1 in c/cagrilintide · 13 points · 4 months ago
tendon and cagrilintide literature in rodents is interesting
comment on genuine question about MHRA that I am slightly embarrassed to ask in c/glp1uk · 0 points · 5 months ago
What is today's date for the pricing?
comment on week 76 check-in — 22kg down, muscle cramps manageable, one thing confusing me in c/cagrilintide · 10 points · 5 months ago
The practical rule people converge on is 28 days at fridge temperature after first puncture, and that comes from the preservative, not the peptide.
comment on [Discussion] can we stop arguing about lyophilised until somebody posts a number in c/coldchain · 14 points · 6 months ago
stability after excursion is not zero, it is dose-dependent
Disagree on that part. 99.2% and 99.3% on the same vial is normal.
comment on [Discussion] reimbursement is doing more work than we give it credit for in c/glp1eu · 1 points · 6 months ago
pricing posts need date and currency
comment on stalled for 22 weeks at 1.0mg and I refuse to panic this time in c/coa · 157 points · 6 months ago
purity and net content are two different numbers, same vial
comment on [Results] 46 weeks on 1.7mg, full numbers, ask me anything boring in c/cagrilintide · 9 points · 6 months ago
Rodent or human data?
comment on anyone else notice co-agonism kicking in around week 5 in c/cagrilintide · 19 points · 7 months ago
CagriSema is a fixed combo in trials, not user-mixed
comment on [Meta] the certificate of analysis rule is doing its job and people should stop complaining in c/coa · 278 points · 7 months ago
purity and net content are two different numbers, same vial
comment on [Discussion] we are measuring tier 3 at the wrong time and calling it noise in c/glp1uk · 20 points · 8 months ago
price posts need the date — UK pricing moves monthly
comment on anyone else notice private prescription kicking in around week 4 in c/glp1uk · 8 points · 8 months ago
NHS tier 3 is NHS, the waiting list is real
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
comment on anyone else notice private prescription kicking in around week 4 in c/glp1uk · 1 points · 8 months ago
Private pharmacy pricing in Sweden: 12.5mg was private prescription this month, 5% up from last month.
comment on anyone else notice private prescription kicking in around week 4 in c/glp1uk · 1 points · 8 months ago
Boots stock check: called 5 locations in the Netherlands, 13 had 2.4mg in stock. Regional variation is real.
comment on [Discussion] the related substances advice in here is 9 years out of date in c/coa · 4 points · 9 months ago
redact your own name, not the vendor's batch details
comment on [Lab] 15th independent test on QSC, and the trend is the interesting part in c/coa · 24 points · 10 months ago
What is the method line say? Not the technique, the actual method.